European Medical Solutions

European Medical Solutions EBIT Margin

The EBIT Margin (Operating Margin) of European Medical Solutions (ALEMS.BR) as of Nov 10, 2026 is 5.37 %. In the previous year, EBIT Margin (Operating Margin) was 4.41 % — a change of 21.63% (higher).

EBIT Margin

5.37 %

YoY

21.63%

Last updated:

EBIT Margin (Operating Margin) of European Medical Solutions is 2025 5.37 % . EBIT Margin (Operating Margin) of European Medical Solutions was 2024 4.41 % . It decreases by 21.63% higher compared to the previous year.

European Medical Solutions's operating (EBIT) margin stands at 5.4%, up from 0.1% several years earlier.

The European Medical Solutions EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
-2,236.88 EUR
Jan 1, 2019
-1,497.97 EUR
Jan 1, 2020
-249.90 EUR
Jan 1, 2021
0.08 EUR
Jan 1, 2022
-14.10 EUR
Jan 1, 2023
-0.33 EUR
Jan 1, 2024
4.41 EUR
Jan 1, 2025
5.37 EUR
The European Medical Solutions EBIT Margin history
YEAREBIT MarginYoY
5.37 %+21.63%
4.41 %-1,426.24%
-0.33 %-97.64%
-14.10 %-18,585.47%
0.08 %-100.03%
-249.90 %-83.32%
-1,497.97 %-33.03%
-2,236.88 %+12.82%
-1,982.62 %+171.79%
-729.46 %-99.62%
-191,000.00 %+121.17%
-86,360.00 %+26,206.35%
-328.29 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

European Medical Solutions Stock analysis

What does European Medical Solutions do? European Medical Solutions SA operates in the Health Care sector, specifically within the biotechnology industry. Headquartered in Liege, Belgium, the company is a clinical-stage biopharmaceutical entity focused on the research and development of immunotherapy treatments for environmental and food allergies. It currently employs 20 full-time staff members. The company listed its shares on the stock exchange on 11 May 2016, marking its entry into public markets while maintaining its focus on advancing novel therapeutic solutions in the allergy treatment space. European Medical Solutions is one of the most popular companies on Eulerpool.

Frequently Asked Questions about European Medical Solutions stock

EBIT Margin (Operating Margin) of European Medical Solutions is 5.37 % in 2025.

EBIT Margin (Operating Margin) of European Medical Solutions changed from 4.41 % to 5.37 %, representing a 21.63% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) European Medical Solutions since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s European Medical Solutions with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — European Medical Solutions

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — European Medical Solutions